Literature DB >> 23289037

Conservative versus surgical treatment of osteogenesis imperfecta: a retrospective analysis of 29 patients.

Eugenio Chiarello1, Davide Donati, Giuseppe Tedesco, Luca Cevolani, Tommaso Frisoni, Matteo Cadossi, Martha Hoque, Benedetta Spazzoli, Sandro Giannini.   

Abstract

The aim of our study was to compare the surgical and conservative treatment of patients affected by fragility fractures and deformities of long bones in osteogenesis imperfecta (OI).Our series consisted of 29 consecutive OI patients treated at our Institute. The series comprised 14 females and 15 males of different ages. The mean age at the time of the first treatment was 8 years (median 6 years; SD ± 15; range 1 to 75). The mean follow-up was 88 months. The Sillence classification was used to classify OI. Fifteen patients were classified as Type I; five as Type III and nine as Type IV.A total number of 245 procedures were recorded. Of these, 147 were surgical (pinning; intramedullary nailing and plating) while 98 were conservative (cast, braces and bandages). Bisphosphonate use was a major variable in the study. Clinical charts and radiographic films were analyzed for complications (delayed union, nonunion, malunion, hardware loosening). We recorded 58 complications: 13 in Type I; 28 in Type III and 17 in Type IV OI. The rate of each complication was: 15/245 nonunions (6.1%), 14/245 delayed unions (5.7%), 14/245 malunions (5.7%) and 15/245 hardware loosenings (6.1%).We found no statistically significant differences between surgical and conservative treatments. Type III OI, which is a very crippling form of the disease, was associated with radiographically poorer results than the other types. In our analysis, the two groups were unbalanced and only five patients were treated with bisphosphonates. Nevertheless, bisphosphonate use can be considered a good adjuvant to both the conservative and surgical treatment of OI in order to reduce the rate of complications.

Entities:  

Keywords:  bisphosphonates; complications; conservative treatment; osteogenesis imperfecta; surgical treatment

Year:  2012        PMID: 23289037      PMCID: PMC3535993     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  24 in total

1.  Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.

Authors:  E Aström; P Magnusson; S Eksborg; S Söderhäll
Journal:  Acta Paediatr       Date:  2010-08-19       Impact factor: 2.299

Review 2.  Electromagnetic field stimulation for treating delayed union or non-union of long bone fractures in adults.

Authors:  Xavier L Griffin; Matthew L Costa; Nick Parsons; Nick Smith
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

3.  Non-union in osteogenesis imperfecta.

Authors:  Vineet Agarwal; Benjamin Joseph
Journal:  J Pediatr Orthop B       Date:  2005-11       Impact factor: 1.041

4.  Bone healing in children with osteogenesis imperfecta treated with bisphosphonates.

Authors:  Javier Pizones; Horacio Plotkin; Jose Ignacio Parra-Garcia; Patricia Alvarez; Pilar Gutierrez; Ana Bueno; Antonio Fernandez-Arroyo
Journal:  J Pediatr Orthop       Date:  2005 May-Jun       Impact factor: 2.324

5.  Non-union of fractures in children who have osteogenesis imperfecta.

Authors:  J G Gamble; L A Rinsky; J Strudwick; E E Bleck
Journal:  J Bone Joint Surg Am       Date:  1988-03       Impact factor: 5.284

6.  Do patients with osteogenesis imperfecta need individualized nutritional support?

Authors:  Carlos Eduardo Andrade Chagas; Janaína Pivetta Roque; Bárbara Santarosa Emo Peters; Marise Lazaretti-Castro; Lígia Araújo Martini
Journal:  Nutrition       Date:  2011-07-27       Impact factor: 4.008

7.  Characterising and treating osteogenesis imperfecta.

Authors:  Nick Bishop
Journal:  Early Hum Dev       Date:  2010-09-16       Impact factor: 2.079

8.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

9.  Treatment of recalcitrant non-union with a capacitively coupled electrical field. A preliminary report.

Authors:  C T Brighton; S R Pollack
Journal:  J Bone Joint Surg Am       Date:  1985-04       Impact factor: 5.284

10.  Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta.

Authors:  F de Graaff; W Verra; J E H Pruijs; R J B Sakkers
Journal:  J Child Orthop       Date:  2011-01-25       Impact factor: 1.548

View more
  5 in total

1.  Hemiarthroplasty of the Hip in a 52-Year-old Patient with Osteogenesis Imperfecta-Related Femoral Neck Fracture: A Case Report.

Authors:  B Maeder; M Hanauer; P Poglia; F Chevalley; E Thein
Journal:  J Orthop Case Rep       Date:  2018 Sep-Oct

2.  Humeral Shaft Non-union in a Patient with Osteogenesis Imperfecta Treated with Mandible Locking Plate Fixation: A Case Report.

Authors:  Shohei Sano; Keisuke Oe; Tomoaki Fukui; Shinya Hayashi; Ryosuke Kuroda; Takahiro Niikura
Journal:  J Orthop Case Rep       Date:  2019

3.  Surgical Treatment of Bilateral Tibia Deformity in a 9-Year-Old Child Suffering from Osteogenesis Imperfecta Type III: A Case Report.

Authors:  Ioannis Delniotis; Benedikt Leidinger
Journal:  Am J Case Rep       Date:  2019-10-21

4.  Incidence and treatment of adult femoral fractures with osteogenesis imperfecta: An analysis of a center of 72 patients in Taiwan.

Authors:  Chung-Lin Lee; Shih-Chia Liu; Chen-Yu Yang; Chih-Kuang Chuang; Hsiang-Yu Lin; Shuan-Pei Lin
Journal:  Int J Med Sci       Date:  2021-01-14       Impact factor: 3.738

5.  Incidence and treatment of femur fractures in adults with osteogenesis imperfecta: an analysis of an expert clinic of 216 patients.

Authors:  Wouter Alexander Goudriaan; Gerrit Jan Harsevoort; Marije van Leeuwen; Antonius Adrianus Franken; Guus Johannes Maria Janus
Journal:  Eur J Trauma Emerg Surg       Date:  2018-09-22       Impact factor: 3.693

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.